NewMeco Obtains Product Approval for Botulinum Toxin "NewLux" in El Salvador
Establishing a Strategy to Leverage Meditox's Local Sales Network
Meditoxt's affiliate, NewMeco, announced on November 26 that it has obtained product approval for its botulinum toxin formulation "NewLux" from the Salvadoran National Directorate of Medicines (SRS).
El Salvador, a major emerging country in Central and South America, is one of the leading nations experiencing rising demand for aesthetic procedures such as botulinum toxin and fillers, driven by economic growth and the influence of social media. Meditox completed registration of its botulinum toxin product "Meditoxin" (export name "Neuronox") in 2009 and its hyaluronic acid filler "Neuramis" in 2020. Based on the synergy between its botulinum toxin and filler products, NewMeco has continued its growth trajectory, and this year expects local sales to increase by more than 50% compared to the previous year.
To ensure the successful market entry of "NewLux," NewMeco is leveraging Meditox's local sales network and developing optimal, customized marketing strategies, including promotions linked with "Neuramis."
A NewMeco representative stated, "With approval in El Salvador, our efforts to expand 'NewLux' across Central and South America have gained further momentum. We will continue to enter major countries in the region and elevate the status of our global toxin brand."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, "NewLux," a next-generation botulinum toxin formulation produced using the latest processes to improve yield and quality, is accelerating its global expansion based on its product competitiveness. Starting with Peru last year, the company has entered Bolivia and the Dominican Republic, pioneering the Central and South American market, and is also expanding into European and Asian markets such as Thailand, Georgia, and Moldova.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.